197 related articles for article (PubMed ID: 36589239)
1. Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma.
Duan Y; Du Y; Mu Y; Gu Z; Wang C
Front Mol Biosci; 2022; 9():1096679. PubMed ID: 36589239
[No Abstract] [Full Text] [Related]
2. Expression, prognostic value and mechanism of SP100 family in pancreatic adenocarcinoma.
Duan Y; Du Y; Mu Y; Gu Z; Wang C
Aging (Albany NY); 2023 Jun; 15(12):5569-5591. PubMed ID: 37354211
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma.
Duan Y; Du Y; Gu Z; Zheng X; Wang C
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142223
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma.
Duan Y; Du Y; Gu Z; Zheng X; Wang C
Front Mol Biosci; 2022; 9():1036287. PubMed ID: 36339709
[No Abstract] [Full Text] [Related]
5.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
Front Immunol; 2021; 12():769425. PubMed ID: 34804059
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.
Li X; Qiu N; Li Q
Front Genet; 2021; 12():758725. PubMed ID: 34804125
[No Abstract] [Full Text] [Related]
8. Comprehensive Analysis of SMC Gene Family Prognostic Value and Immune Infiltration in Patients With Pancreatic Adenocarcinoma.
Nie H; Wu Y; Ou C; He X
Front Med (Lausanne); 2022; 9():832312. PubMed ID: 35372377
[TBL] [Abstract][Full Text] [Related]
9.
Wu Q; Li J; Wang P; Peng Q; Kang Z; Deng Y; Li J; Yan D; Ge F; Chen Y
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36981005
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma.
Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X
Front Genet; 2022; 13():848391. PubMed ID: 35601487
[No Abstract] [Full Text] [Related]
11. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.
Cui Z; Du L; Wang J; Li Z; Xu J; Ou S; Li D; Li S; Hu H; Chen G; Wu Z
BMC Cancer; 2022 Dec; 22(1):1354. PubMed ID: 36572856
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.
Gong Q; Dong Q; Zhong B; Zhang T; Cao D; Zhang Y; Ma D; Cai X; Li Z
J Clin Lab Anal; 2022 Dec; 36(12):e24784. PubMed ID: 36408702
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma.
Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
[TBL] [Abstract][Full Text] [Related]
15. Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
Wang W; Zhang D; Chang D; Li Y; Ren L
Mol Cell Probes; 2023 Feb; 67():101897. PubMed ID: 36740149
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
[TBL] [Abstract][Full Text] [Related]
17. Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer.
Zhang J; Tian Y; Mo S; Fu X
Int J Gen Med; 2022; 15():3077-3096. PubMed ID: 35330878
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.
Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB
J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690
[TBL] [Abstract][Full Text] [Related]
19. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma.
Li Y; Su Z; Wei B; Liang Z
Int J Gen Med; 2021; 14():2677-2694. PubMed ID: 34188523
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
